-+ 0.00%
-+ 0.00%
-+ 0.00%
Johnson & Johnson Expands Robotic Bronchoscopy Push With AI, 3D Navigation Upgrade
Share
Listen to the news

Johnson & Johnson (NYSE:JNJ) on Monday secured U.S. 510(k) regulatory clearance for MONARCH QUEST 3, the newest software iteration for its robotically-assisted bronchoscopy platform.

The update focuses on improving clinical confidence during complex airway procedures and marks the fourth launch for the MONARCH system in the past 18 months, demonstrating a clear push for continuous medical innovation.

Advances Robotic Bronchoscopy

The MONARCH system operates as the first flexible, robotically-assisted platform designed to help physicians visualize and access patient airways for diagnostic and therapeutic procedures.

With the QUEST 3 update, the healthcare company addresses anatomical changes and CT-to-body divergence that frequently happen during clinical interventions, giving physicians precise control and stable reach.

AI And Imaging Upgrades

The software release introduces AI-powered nodule segmentation, allowing clinicians to automatically generate accurate nodule boundaries with a single click before a procedure begins.

It also deploys software enhancements to improve navigation accuracy as a patient’s anatomy shifts.

Additionally, a new 3D Compass overlay simplifies scope-tip orientation by aligning joystick movements with patient anatomy. The software also expands compatibility with mobile and fixed cone-beam computed tomography (CBCT) imaging systems, enabling medical facilities to use current imaging infrastructure to better target lung nodules.

Integrating Digital Ecosystems

MONARCH QUEST 3 incorporates Polyphonic, the open digital ecosystem developed by Johnson & Johnson. The integration extends surgical intelligence beyond the operating room.

Clinicians can review procedural volume data and collaborate with colleagues through a centralized video library.

Polyphonic organizes each case into a consistent format, making it easier for medical teams to revisit key moments and support ongoing learning.

Price Action

JNJ Stock Price Activity: Johnson & Johnson shares were up 0.58% at $272.68 at the time of publication on Wednesday, according to Benzinga Pro data.

Image via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending